Viewing Study NCT00660660


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-25 @ 8:15 PM
Study NCT ID: NCT00660660
Status: COMPLETED
Last Update Posted: 2015-03-02
First Post: 2008-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastroesophageal Reflux Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GERD View
None Esophageal Reflux View
None Gastro-Esophageal Reflux View
None Regurgitation View
None Gastric View